67 related articles for article (PubMed ID: 34517553)
21. Tumor microenvironment characteristics and prognostic role of m
Li P; Xiong P; Li X; Zhang X; Chen X; Zhang W; Jia B; Lai Y
Heliyon; 2024 Mar; 10(5):e26851. PubMed ID: 38455573
[TBL] [Abstract][Full Text] [Related]
22. Identification of m6A-associated autophagy genes in non-alcoholic fatty liver.
Huang Z; Luo L; Wu Z; Xiao Z; Wen Z
PeerJ; 2024; 12():e17011. PubMed ID: 38436022
[TBL] [Abstract][Full Text] [Related]
23. Construction of a prognostic model for autophagy in Wilm's tumor.
Shi H; Zhang M; Zhang Y
Pediatr Surg Int; 2024 May; 40(1):122. PubMed ID: 38704513
[TBL] [Abstract][Full Text] [Related]
24. Identification of marker genes associated with N6-methyladenosine and autophagy in ulcerative colitis.
Liu XY; Qiao D; Zhang YL; Liu ZX; Chen YL; Que RY; Cao HY; Dai YC
World J Clin Cases; 2024 Apr; 12(10):1750-1765. PubMed ID: 38660076
[TBL] [Abstract][Full Text] [Related]
25. Five crucial prognostic-related autophagy genes stratified female breast cancer patients aged 40-60 years.
Li X; Zhang H; Liu J; Li P; Sun Y
BMC Bioinformatics; 2021 Dec; 22(1):580. PubMed ID: 34876005
[TBL] [Abstract][Full Text] [Related]
26. A novel model for identification of prognostic indicator for clinical outcome of squamous cell lung carcinoma.
Duan K; Li L; Tan XD; Yin P
Tumour Biol; 2016 Nov; ():. PubMed ID: 27830468
[TBL] [Abstract][Full Text] [Related]
27. Experimental prognostic model integrating N6-methyladenosine-related programmed cell death genes in colorectal cancer.
Wu Q; Fu X; He X; Liu J; Li Y; Ou C
iScience; 2024 Jan; 27(1):108720. PubMed ID: 38299031
[TBL] [Abstract][Full Text] [Related]
28. Retracted: Construction of an Immune-Autophagy Prognostic Model Based on ssGSEA Immune Scoring Algorithm Analysis and Prognostic Value Exploration of the Immune-Autophagy Gene in Endometrial Carcinoma (EC) Based on Bioinformatics.
Healthcare Engineering JO
J Healthc Eng; 2023; 2023():9834327. PubMed ID: 37860371
[TBL] [Abstract][Full Text] [Related]
29. Comprehensive analysis of EMT-related genes and lncRNAs in the prognosis, immunity, and drug treatment of colorectal cancer.
Yang Y; Feng M; Bai L; Liao W; Zhou K; Zhang M; Wu Q; Wen F; Lei W; Zhang P; Zhang N; Huang J; Li Q
J Transl Med; 2021 Sep; 19(1):391. PubMed ID: 34526059
[TBL] [Abstract][Full Text] [Related]
30. A Prognostic Nomogram for Predicting Overall Survival in Pediatric Wilms Tumor Based on an Autophagy-related Gene Signature.
He L; Wang X; Jin Y; Xu W; Lyu J; Guan Y; Wu J; Han S; Liu G
Comb Chem High Throughput Screen; 2022; 25(8):1385-1397. PubMed ID: 34525929
[TBL] [Abstract][Full Text] [Related]
31. Biomarker Screening and Prognostic Significance Analysis for Renal Cell Carcinoma.
Meng X; Yuan H; Li W; Xiao W; Zhang X
Int J Gen Med; 2021; 14():5255-5267. PubMed ID: 34522125
[TBL] [Abstract][Full Text] [Related]
32. Integrated analysis identifies TfR1 as a prognostic biomarker which correlates with immune infiltration in breast cancer.
Chen F; Fan Y; Hou J; Liu B; Zhang B; Shang Y; Chang Y; Cao P; Tan K
Aging (Albany NY); 2021 Sep; 13(17):21671-21699. PubMed ID: 34518441
[TBL] [Abstract][Full Text] [Related]
33. The methylation modification of m6A regulators contributes to the prognosis of head and neck squamous cell carcinoma.
Chen Y; Jiang X; Li X; Yan D; Liu J; Yang J; Yan S
Ann Transl Med; 2021 Aug; 9(16):1346. PubMed ID: 34532483
[TBL] [Abstract][Full Text] [Related]
34. Characterization of m6A-Related Genes Landscape in Skin Cutaneous Melanoma to Aid Immunotherapy and Assess Prognosis.
Meng J; Huang X; Qiu Y; Yu M; Lu J; Yao J
Int J Gen Med; 2021; 14():5345-5361. PubMed ID: 34522131
[TBL] [Abstract][Full Text] [Related]
35. Exosomal microRNA-19b targets FBXW7 to promote colorectal cancer stem cell stemness and induce resistance to radiotherapy.
Sun T; Yin YF; Jin HG; Liu HR; Tian WC
Kaohsiung J Med Sci; 2022 Feb; 38(2):108-119. PubMed ID: 34520626
[TBL] [Abstract][Full Text] [Related]
36. A novel prognostic signature based on four glycolysis-related genes predicts survival and clinical risk of hepatocellular carcinoma.
Chen Z; Zou Y; Zhang Y; Chen Z; Wu F; Shi N; Jin H
J Clin Lab Anal; 2021 Nov; 35(11):e24005. PubMed ID: 34523732
[TBL] [Abstract][Full Text] [Related]
37. DPYSL2 as potential diagnostic and prognostic biomarker linked to immune infiltration in lung adenocarcinoma.
Wu YJ; Nai AT; He GC; Xiao F; Li ZM; Tang SY; Liu YP; Ai XH
World J Surg Oncol; 2021 Sep; 19(1):274. PubMed ID: 34517904
[TBL] [Abstract][Full Text] [Related]
38. An integrated model of
Zhang K; Han Z; Zhao H; Liu S; Zeng F
Ann Transl Med; 2021 Oct; 9(20):1523. PubMed ID: 34790729
[TBL] [Abstract][Full Text] [Related]
39. Role of CXCR4 as a Prognostic Biomarker Associated With the Tumor Immune Microenvironment in Gastric Cancer.
Gu Y; Gu W; Xie R; Chen Z; Xu T; Fei Z
Front Cell Dev Biol; 2021; 9():654504. PubMed ID: 34568309
[No Abstract] [Full Text] [Related]
40. Development and Verification of a Prostate Cancer Prognostic Signature Based on an Immunogenomic Landscape Analysis.
Cheng H; Wang Y; Liu C; Wu T; Chen S; Chen M
Front Oncol; 2021; 11():711258. PubMed ID: 34568039
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
